Pharma regulatory norms to be revamped: DCGI
THE apex drug regulatory body has decided to shed its indigenous regulatory approach for a more global one compatible to the needs of the international market.

Biocon’s public offer opens on March 11
Biocon Ltd, India’s largest biotechnology company is entering the capital markets with its Initial Public Offering (IPO). The company has opted for the 100 per cent book building method for efficient price discovery.

Probiotics: The future of Indian healthcare industry
THE future of healthcare lies in probiotics - that is what the consensus attained at a recent symposium titled ‘All About Probiotics’ organised by Indian Health-food and Dietary Supplements Association (INHADSA) in alliance with Lallemand Human Nutritions, a division of Institut Rosell, a Canadian based giant in Probiotics and their Indian counterparts Arun & Co (Zytex).

Generics cos face greater biz risk: Aon
Bigger companies should go in for what is known as ‘pooling arrangements’ which was one of the methods of the many propositions taken up by Aon in order to mitigate risks, said Ted Hodgkinson, regional director of merger and acquisitions and financial services, Aon Asia, Hong Kong. .

Novartis explores marketing, R&D collaborations in India
Swiss drug major Novartis is exploring collaborations with Indian pharmaceutical companies in the areas of licensing, R&D and marketing.

Noveon, UICT organise seminar on Carbopol polymer
Noveon and the Pharmaceutical Division of the Mumbai University Institute of Chemical Technology (MUICT) jointly organised a seminar on Carbopol — a versatile polymer.

Dr Saran Narang joins NPIL scientific board
NICHOLAS Piramal has inducted Dr Saran Narang into company’s scientific advisory board.

Four indigenous microbicides to hit Indian market
While female condom launched by Hindustan Lever Ltd may remain an expensive and unpopular option among the larger section of women, the emergence of microbicides spring up hopes in HIV/ AIDS control.